Associated Papers
Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light Smokers.
Terashima Y et al.
Cancer Science, 2025
40734624 (PubMed )
Supplement: CAS-116-2868-s002.xlsx › Table_S3
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Caughey BA et al.
Journal of Gastrointestinal Oncology, 2023
Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer.
Jin W
Cancers, 2020
Molecular Profiling of Synchronous Colon Cancers and Anaplastic Thyroid Cancer in a Patient with Lynch Syndrome.
Johnson JM et al.
Journal of Gastrointestinal Cancer, 2018
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.
Luo Y et al.
Plos Genetics, 2013
Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
Kubo T et al.
Pancreas, 2009
No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell lines.
Shao RX et al.
Journal of Gastroenterology, 2005
Select a paper to view details